Biocon arm receives tentative USFDA approval for tablets used to treat stomach ailments

The tablets are a rifamycin antibacterial indicated for reducing the risk of overt hepatic encephalopathy recurrent and to treat irritable bowel syndrome with diarrhoea in adults, according to Biocon.

Leave a Reply

Your email address will not be published. Required fields are marked *